HEALTH ALERT! If you have any of the following, please call our office before coming in for your appointment: Fever AND cough; Fever OR cough and recent travel (domestic or international to any destination); Recent international travel to areas impacted by the Coronavirus (2019-nCoV) within the last 14 days; OR close contact with someone who has traveled outside the US or been exposed to the Coronavirus. Read more

USOR 11282/SGN35-015 STAR Brentix in Older Pts w/HL 1L 1st Line

USOR 11282 A Phase 2, Open-Label Study, of Brentuximab Vedotin for Front-Line Therapy of Hodgkin Lymphoma (HL) and CD30-Expressing Peripheral T-Cell Lymphoma (PTCL) in Adults Age 60 and Above.(SGN35-015)

Disease Types: Lymphoma,&nbs

Available at: Niles

Principal Investigator: {clinical_trial_principle_investi} , {/clinical_trial_principle_investi}

{clinical_trial_description}